Literature DB >> 19050179

A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids.

Bradley Van Voorhis1.   

Abstract

Uterine fibroids are common tumors that can cause heavy menstrual bleeding, pelvic pressure symptoms, and reproductive disorders. The incidence of fibroids peaks in the fifth decade of age and they are more common in African American women. Often, fibroids are asymptomatic and require no treatment. However, the case of Ms P, a 41-year-old woman with recurrent uterine fibroids, menorrhagia, anemia, and fatigue who wishes to retain fertility, illustrates the symptoms that require treatment. Evaluation usually begins with a pelvic examination and an ultrasound to determine both the size and location of the fibroids within the uterus. Standard treatment of symptomatic fibroids is surgical removal by myomectomy or hysterectomy, depending in part on the desire for future fertility; new treatment options include uterine artery embolization via interventional radiologic techniques as well as various medical interventions. Several new therapies show promise but are still experimental at this time. The evidence for treatment options for Ms P and symptomatic patients with fibroids in general is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19050179     DOI: 10.1001/jama.2008.791

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

Review 1.  Pathophysiology of heavy menstrual bleeding.

Authors:  Dharani K Hapangama; Judith N Bulmer
Journal:  Womens Health (Lond)       Date:  2015-12-23

Review 2.  Selective progesterone receptor modulators (SPRMs) for uterine fibroids.

Authors:  Ally Murji; Lucy Whitaker; Tiffany L Chow; Mara L Sobel
Journal:  Cochrane Database Syst Rev       Date:  2017-04-26

Review 3.  Urological complications of uterine leiomyoma: a review of literature.

Authors:  Gautam Dagur; Yiji Suh; Kelly Warren; Navjot Singh; John Fitzgerald; Sardar A Khan
Journal:  Int Urol Nephrol       Date:  2016-02-27       Impact factor: 2.370

4.  Acute on chronic anaemia with a haemoglobin of 18 g/L (1.8 g/dL) and haematocrit of 7.2.

Authors:  Shelly Fay Haferkamp; Sundar Venkata Cherukuri; Sri Laxmi Valasareddi; Amith Skandhan
Journal:  BMJ Case Rep       Date:  2018-12-22

5.  Functional gene polymorphism of matrix metalloproteinase-1 is associated with benign hyperplasia of myo- and endometrium in the Russian population.

Authors:  Elena B Morosova; Alexei B Chukhlovin; Natalia V Kulagina; Natalia V Kipich; Areg A Totolian
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-01

6.  Impact of periodic health examination on surgical treatment for uterine fibroids in Beijing: a case-control study.

Authors:  Hai-Yun Wu; Ling-Ling Yang; Shan Zhou
Journal:  BMC Health Serv Res       Date:  2010-12-07       Impact factor: 2.655

7.  Iron Deficiency Anemia With a Life-Threatening Low Hemoglobin Level.

Authors:  Abdulrahman M Alateeq; Hessa A Alshammari; Abdulmalik M Alsaif
Journal:  Cureus       Date:  2021-12-04

8.  Diagnosis and treatment of submucous myoma of the uterus with interventional ultrasound.

Authors:  Bo Liang; Yang-Gui Xie; Xiao-Ping Xu; Chun-Hong Hu
Journal:  Oncol Lett       Date:  2018-02-27       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.